Viatris
Viatris (VTRS) is a global healthcare company formed in 2020 through the merger of Mylan and Upjohn, a division of Pfizer. The company operates in the pharmaceutical sector, focusing on providing access to medicines across a wide range of therapeutic areas, including infectious diseases, cardiovascular health, diabetes, and oncology. Viatris offers a diverse portfolio of generic and branded medications, over-the-counter products, and biosimilars, aiming to improve patient health outcomes worldwide.